Regenerative Medicine
Regeneration is Not
a Promise. It's a Process.
Atunse's regenerative medicine framework spans exosome science, cellular therapy, and precision biologics — each delivered within the KIARMA Regenerative Care Cycle. From Exosome Support Therapy (EST) to NK Cell and MSC therapy, every intervention is physician-guided, evidence-informed, and patient-specific.
The Science
Beyond Treatment.
Toward Restoration.
The burden of osteoarthritis and musculoskeletal disability is substantial across Africa — affecting mobility, employment, caregiving, and community life. Access to advanced orthopedic surgery is often limited. Regenerative medicine offers a disciplined middle path.
But regenerative medicine can also be vulnerable to exaggerated claims, poor product control, and insufficient outcome tracking. Atunse exists precisely to bridge this gap in Africa — training clinicians to deliver care that is scientifically grounded, ethically communicated, and locally practical.
At Atunse, regeneration is not a product. It is a care ecosystem: staging the disease, identifying the repair window, aligning the intervention with evidence, restoring functional loading, and auditing every outcome.
"Regenerative medicine is not a promise that every damaged tissue can be rebuilt. It is a disciplined clinical strategy for identifying repairable biological environments and creating conditions for organized repair. That is the Atunse standard.
The Atunse Clinical Team
The Atunse Thread
Exosome Support
Therapy (EST)
Exosomes are nanoscale extracellular vesicles — naturally secreted by cells as part of biological communication. They carry lipids, proteins, and nucleic acids that modulate cellular behaviour, support tissue signaling, and influence the local biological environment.
At Atunse, Exosome Support Therapy is the regenerative thread woven through every service pathway. Whether delivered topically alongside shockwave therapy, locally at a treatment site, or systemically via IV infusion as part of the Longevity & Vitality Program — EST is applied as a precision signaling tool, not a standalone cure. Every application is physician-designed, patient-specific, and governed by clinical eligibility assessment.
Exosome therapy is an investigational therapeutic category. All Atunse EST protocols are conducted under physician oversight, with documented consent and individual clinical eligibility assessment. Outcomes are not guaranteed.
EST is integrated across
Clinical Focus Areas
Where Regenerative Medicine
Creates Real Clinical Impact.
Each focus area connects Atunse's regenerative toolkit — EST, NK Cell Therapy, and MSC Therapy — to a defined clinical domain. These are not isolated therapies. They are interconnected biological strategies, applied within the KIARMA Regenerative Care Cycle.
Repair. Rebuild. Restore Function.
Musculoskeletal disease — from osteoarthritis and tendinopathy to joint degeneration — remains one of the most disabling conditions across Africa. Regenerative medicine offers a disciplined, evidence-informed middle path between pain management and surgery.
Exosome Support Therapy (EST)
Delivered locally to joints and soft tissue, exosomes modulate the inflammatory environment, support tissue signaling, and create conditions for organized biological repair. EST is integrated with shockwave therapy in every Atunse musculoskeletal protocol.
MSC Therapy
Mesenchymal stem cells are multipotent stromal cells with documented immunomodulatory and paracrine signaling properties. In the musculoskeletal context, MSCs influence the local tissue environment — supporting cartilage health, reducing inflammatory cascades, and facilitating repair in eligible patients.
Platelet-Rich Plasma (PRP)
An autologous blood-derived preparation that concentrates platelets and growth factors. Supported by evidence in mild-to-moderate knee osteoarthritis and select tendinopathies — applied within the KIARMA Repair Window framework.
Viscosupplementation
Hyaluronic acid and joint-environment modifiers to improve lubrication and reduce pain in selected patients — applied as part of the broader tissue ecosystem strategy.
Connected Atunse Services
Radial Shockwave Therapy · Focused Shockwave Therapy
Biology Beyond the Joint.
Metabolic dysfunction and cardiovascular decline share a common biological root: chronic low-grade inflammation, endothelial stress, mitochondrial inefficiency, and dysregulated cellular signaling. Regenerative medicine addresses these at the cellular level — not just the symptomatic surface.
MSC Therapy
MSCs are among the most studied regenerative tools in metabolic and cardiovascular contexts. Their immunomodulatory and paracrine properties can influence inflammatory signaling pathways relevant to insulin resistance, endothelial function, and vascular biology — applied under physician governance and individual eligibility assessment.
Exosome Support Therapy (EST)
Systemically delivered via IV infusion, exosomes carry signaling molecules that can reach distant tissue environments. In metabolic and cardiovascular applications, EST supports cellular communication, mitochondrial function, and anti-inflammatory signaling pathways.
Peptide Protocols
Targeted peptide administration to modulate hormonal balance, metabolic pathways, and vascular health — structured as a precision clinical protocol within the KIARMA Know & Align domains.
Connected Atunse Services
Longevity & Vitality Program · Men's Intimate Wellness
Regeneration at the Surface.
Aesthetic medicine is increasingly understood as biological medicine. Skin quality, tissue architecture, collagen integrity, and cellular renewal are not superficial concerns — they reflect the functional status of the body's largest organ and its underlying regenerative capacity.
Exosome Support Therapy (EST)
In aesthetic applications, exosomes are delivered topically and in conjunction with acoustic wave therapy to support collagen and connective tissue environments, improve cellular communication at the skin level, and contribute to tissue quality from within. EST is the regenerative thread woven through every Atunse aesthetic protocol.
MSC Therapy
MSCs contribute paracrine signals that influence the tissue microenvironment — including collagen remodeling, angiogenesis, and cellular turnover. In aesthetic contexts, MSC-derived biological signals can support the structural environment underlying skin quality and appearance.
Acoustic Wave Therapy
Non-invasive acoustic energy to support tissue quality, skin texture, and aesthetic appearance — combined with EST at Atunse for a regenerative signaling approach that extends beyond surface-level treatment.
Connected Atunse Services
Acoustic Wave Therapy
The Science of Aging Well.
Longevity medicine is not about living longer at any cost — it is about extending the period of human function, vitality, and independence. The biological drivers of aging — cellular senescence, mitochondrial decline, immune dysregulation, and systemic inflammation — are increasingly modifiable. Atunse's approach addresses them all.
NK Cell Therapy
Natural Killer cells are innate immune effectors with the capacity to detect and eliminate stressed, senescent, and aberrant cells — including potential malignant transformations. NK cell surveillance is one of the body's primary cancer-defence mechanisms, and NK cell activity declines with age. Atunse supports NK cell function as a pillar of longevity biology and immune resilience.
Exosome Support Therapy (EST)
Delivered systemically via IV infusion as part of the Longevity & Vitality Program, EST provides the biological signaling infrastructure for cellular renewal — supporting mitochondrial function, tissue communication, and the biological environment of aging tissues throughout the body.
MSC Therapy
MSCs contribute to longevity biology through their capacity to influence senescent cell environments, modulate systemic inflammation, and support tissue homeostasis. As biological architects of the tissue microenvironment, MSCs are positioned at the intersection of regenerative and longevity medicine.
Peptide Protocols & Metabolic Optimization
Targeted peptides, hormonal balance, sleep architecture, and metabolic precision complete the longevity framework — addressing the systems-level drivers of biological aging alongside cellular and molecular interventions.
Connected Atunse Services
Longevity & Vitality Program · NK Cell Therapy · MSC Therapy
Our Clinical Standards
The KIARMA Repair Window
Atunse clinicians are trained to identify a repair window before any intervention. This window is widest when tissue damage is early or moderate, inflammatory drivers are modifiable, and the patient can engage in rehabilitation. Patient selection is the most important clinical skill in regenerative medicine.
Translational Clinical Science
KIARMA positions regenerative medicine as disciplined, evidence-informed clinical science — not commercial enthusiasm. We do not claim to regrow cartilage, reverse end-stage disease, or guarantee outcomes. Every treatment decision is governed by evidence grade, staging, and honest consent.
Rehabilitation is Mandatory
A biologic intervention creates an opportunity; rehabilitation converts that opportunity into function. Every Atunse patient receives a structured, staged rehabilitation program. The injection is never the whole treatment — the entire biological and functional program is.
African Evidence Generation
African patients are underrepresented in regenerative medicine literature. Atunse contributes to responsible African evidence through a clinical outcomes registry, adverse-event reporting, and ethical research — building the data Africa needs on its own terms.